A comparison between optimal and actuarial health care costs of adolescents with diabetes

被引:6
作者
Cameron, FJ
Widdison, J
Boyce, D
Gebert, R
机构
[1] Royal Childrens Hosp, Dept Endocrinol & Diabet, Melbourne, Vic, Australia
[2] Royal Childrens Hosp, Clin Anal & Dev Unit, Melbourne, Vic, Australia
关键词
adolescents; costs of care; diabetes;
D O I
10.1111/j.1440-1754.2004.00292.x
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objective: To assess actuarial cost and cost of optimal standards of care for adolescents with type 1 diabetes in a tertiary, hospital-based care setting. To also assess actuarial costs of diabetic adolescents in psychosocial crisis. Methods: Contact diaries were maintained over a 1-year period (June 1999-June 2000). Contacts recorded included both structured and non-structured clinical encounters with contact times recorded. In addition, optimal or 'ideal' hospital-based support and contact times for adolescents were estimated and recorded in minutes per year. Three illustrative cases of adolescents in psychosocial crisis were also assessed in terms of actuarial health care professional contact times. Costs were then calculated according to Victorian hospital pay structures per professional for 1999-2000. Results: The mean and median actuarial costs of caring for patients aged between 10 and 19 years were $A1307 per year and $A515 per year, respectively. The cost of optimal care for an adolescent was estimated at $A2817 per year after the first year of diagnosis. The costs per year of the three adolescents in crisis ranged from $A10 137 per year to $A30 524 per year. Conclusions: Cost benefits may be seen in the short term by reducing the number of adolescents who end up in psychosocial crisis. Current actuarial costs of diabetic care for adolescents falls short of an optimal standard of care. Diabetic adolescents who fall into psychosocial crisis consume a disproportionate share of a limited clinical resource.
引用
收藏
页码:56 / 59
页数:4
相关论文
共 12 条
[1]  
Garattini L, 2001, Value Health, V4, P251, DOI 10.1046/j.1524-4733.2001.43022.x
[2]   The cost of insulin-dependent diabetes mellitus (IDDM) in England and Wales [J].
Gray, A ;
Fenn, P ;
McGuire, A .
DIABETIC MEDICINE, 1995, 12 (12) :1068-1076
[3]  
Hampson S E, 2001, Health Technol Assess, V5, P1
[4]   The effects of treatment on the direct costs of diabetes [J].
Herman, WH ;
Eastman, RC .
DIABETES CARE, 1998, 21 :C19-C24
[5]   The cost-effectiveness of intensive therapy for diabetes mellitus [J].
Herman, WH ;
Dasbach, EJ ;
Songer, TJ ;
Eastman, RC .
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 1997, 26 (03) :679-+
[6]   Excess costs of medical care 1 and 8 years after diagnosis of diabetes:: estimates from young and middle-aged incidence cohorts in Sweden [J].
Jonsson, PM ;
Marké, LÅ ;
Nyström, L ;
Wall, S ;
Östman, J .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2000, 50 (01) :35-47
[7]   Effect of future costs on cost-effectiveness of medical interventions among young adults - The example of intensive therapy for type 1 diabetes mellitus [J].
Meltzer, D ;
Egleston, B ;
Stoffel, D ;
Dasbach, E .
MEDICAL CARE, 2000, 38 (06) :679-685
[8]   Improving health care .1. The clinical value compass [J].
Nelson, EC ;
Mohr, JJ ;
Batalden, PB ;
Plume, SK .
JOINT COMMISSION JOURNAL ON QUALITY IMPROVEMENT, 1996, 22 (04) :243-258
[9]   The cost-effectiveness of different management strategies for Type I diabetes: a Swiss perspective [J].
Palmer, AJ ;
Weiss, C ;
Sendi, PP ;
Neeser, K ;
Brandt, A ;
Singh, G ;
Wenzel, H ;
Spinas, GA .
DIABETOLOGIA, 2000, 43 (01) :13-26
[10]  
RUBIN RJ, 1994, J CLIN ENDOCR METAB, V78, P809